Hsu Po-Ke, Kor Chew-Teng, Hsieh Yao-Peng
Department of Internal Medicine, Changhua Christian Hospital, Changhua 50006, Taiwan.
School of Medicine, Kaohsiung Medical University, Kaohsiung 80708, Taiwan.
J Clin Med. 2018 Dec 14;7(12):550. doi: 10.3390/jcm7120550.
The incidence rates of diabetes mellitus (DM) and chronic kidney disease (CKD) are increasing worldwide and their coexistence can have a large negative impact on clinical outcomes. However, it is unclear how incident DM affects CKD patients.
Incident CKD patients between 2000 and 2013 were identified from the National Health Insurance Research Database of Taiwan; they were classified as non-DM ( = 10,356), pre-existing DM ( = 6982), and incident DM ( = 1103). Non-DM cases were patients who did not develop DM before the end of the observation period. The outcomes of interest were end-stage renal disease (ESRD), mortality, and composite outcome (ESRD or death). The association between the DM groups and clinical outcomes was estimated using the inverse probability of group-weighted (IPW) multivariate-adjusted time-dependent Cox regression models.
During the study period of 14 years, 1735 (16.6%) patients in the non-DM group reached ESRD compared with 2168 (31.05%) in the pre-existing DM group and 111 (11.03%) in the incident DM group ( 0.001). Moreover, 2219 (21.43%) patients in the non-DM group died compared with 1895 (27.14%) in the pre-existing DM group and 303 (27.47%) in the incident DM group ( 0.001). Compared with the non-DM group, the pre-existing DM group was associated with a higher risk of ESRD [hazard ratio (HR) 2.54; 95% confidence interval (CI 2.43⁻2.65), death (HR 2.23; 95% CI 2.14⁻2.33), and a composite outcome (HR 2.29; 95% CI 2.21⁻2.36). Similarly, incident DM was also associated with a higher risk of ESRD (HR 1.12; 95% CI 1.06⁻1.19), death (HR 2.48; 95% CI 2.37⁻2.60), and a composite outcome (HR 1.77; 95% CI 1.70⁻1.84) compared with the non-DM group. Factors contributing to incident DM included old age, low monthly income, and having hypertension, hyperlipidemia, and ischemic heart disease, while pentoxifylline reduced the risk of incident DM.
Similarly to pre-existing DM, CKD patients with incident DM carried a higher risk of ESRD, mortality, and a composite outcome compared with those with non-DM. For those at risk of incident DM, strict monitoring and intervention strategies must be adopted to help improve their clinical outcomes.
糖尿病(DM)和慢性肾脏病(CKD)的发病率在全球范围内呈上升趋势,二者并存会对临床结局产生重大负面影响。然而,新发糖尿病如何影响CKD患者尚不清楚。
从台湾国民健康保险研究数据库中识别出2000年至2013年间的新发CKD患者;将他们分为非糖尿病组(n = 10356)、既往糖尿病组(n = 6982)和新发糖尿病组(n = 1103)。非糖尿病病例是指在观察期结束前未发生糖尿病的患者。感兴趣的结局是终末期肾病(ESRD)、死亡率和复合结局(ESRD或死亡)。使用组加权逆概率(IPW)多变量调整的时间依赖性Cox回归模型估计糖尿病组与临床结局之间的关联。
在14年的研究期间,非糖尿病组有1735例(16.6%)患者发展为ESRD,而既往糖尿病组为2168例(31.05%),新发糖尿病组为111例(11.03%)(P < 0.001)。此外,非糖尿病组有2219例(21.43%)患者死亡,既往糖尿病组为1895例(27.14%),新发糖尿病组为303例(27.47%)(P < 0.001)。与非糖尿病组相比,既往糖尿病组发生ESRD的风险更高[风险比(HR)2.54;95%置信区间(CI)2.43⁻2.65]、死亡风险更高(HR 2.23;95% CI 2.14⁻2.33)以及复合结局风险更高(HR 2.29;95% CI 2.21⁻2.36)。同样,与非糖尿病组相比,新发糖尿病组发生ESRD的风险也更高(HR 1.12;95% CI 1.06⁻1.19)、死亡风险更高(HR 2.48;95% CI 2.37⁻2.60)以及复合结局风险更高(HR 1.77;95% CI 1.70⁻1.84)。导致新发糖尿病的因素包括老年、月收入低以及患有高血压、高脂血症和缺血性心脏病,而己酮可可碱可降低新发糖尿病的风险。
与既往糖尿病患者类似,新发糖尿病的CKD患者与非糖尿病患者相比,发生ESRD、死亡和复合结局的风险更高。对于有新发糖尿病风险的患者,必须采取严格的监测和干预策略以帮助改善其临床结局。